Login:

username:
password:

New to sessions.thyroid.org?

Create Account

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conferences:

Conference Years:

Days Within Conference

Do I Have Access?

Access:

Availability:

84th Annual Meeting of the American Thyroid Association

Browse by: Sort by:
<< first | < prev page: of 5 records per page: next > | last >>
pages: 1 2 3 4 5 presentations: 1 to 25 of 123 from 84th Annual Meeting of the American Thyroid Association
Opening Session: Recent Developments and Future Challenges in Thyroidology
Basic Review
Peter A. Kopp, MD
Northwestern University
from 84th Annual Meeting of the American Thyroid Association on October 29, 2014 5:45 PM-7:30 PM
Opening Session: Recent Developments and Future Challenges in Thyroidology
Clinical Endocrine Review
Douglas S. Ross, MD
Massachusetts General Hospital
from 84th Annual Meeting of the American Thyroid Association on October 29, 2014 5:45 PM-7:30 PM
Opening Session: Recent Developments and Future Challenges in Thyroidology
Surgical Review
Herbert Chen, MD
University of Wisconsin
from 84th Annual Meeting of the American Thyroid Association on October 29, 2014 5:45 PM-7:30 PM
Early Riser Symposium: Medullary Thyroid Cancer
Prophylactic Thyroidectomy in MEN2: When and Why?
Steven G. Waguespack, MD
The University of Texas M. D. Anderson Cancer Center
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 6:45 AM-8:00 AM
Early Riser Symposium: Medullary Thyroid Cancer
Management of Persistent/Recurrent Disease in the Neck
Jeffrey F. Moley, MD
Washington University School of Medicine
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 6:45 AM-8:00 AM
Early Riser Symposium: Medullary Thyroid Cancer
Management of Persistent/Recurrent Disease in Distant Sites
Manisha H. Shah, MD
The Ohio State University
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 6:45 AM-8:00 AM
Early Riser Symposium: Medullary Thyroid Cancer
Audience Response and Questions
Jennifer A. Sipos
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 6:45 AM-8:00 AM
Plenary Lecture
Clinical, Ethical and Legal Implications of Incidental Germ Line Findings Discovered as Part of Sequencing Studies
Mark E. Robson, MD
Memorial Sloan Kettering Cancer Center
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 8:10 AM-8:55 AM
Highlighted Oral Abstract Session
Highlighted Oral 1, Autoimmunity, Clinical: DOUBLE VISION IS THE MOST COMMON INDICATION FOR THERAPY IN MODERATE TO SEVERE GRAVES' ORBITOPATHY BUT IT CORRELATES NEGATIVELY WITH INFLAMMATORY SIGNS AND PROPTOSIS. A SINGLE CENTER PROSPECTIVE COHORT STUDY (N=215) WITH OBJECTIVE QUANTITATION OF DIPLOPIA; P. Laurberg, D.C. Berman, I.B. Pedersen, S. Andersen, A. Carlé
Peter Laurberg, MD
Aarhus University Hospital
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 9:00 AM-10:00 AM
Highlighted Oral Abstract Session
Highlighted Oral 2, Autoimmunity, Translational: CRYSTAL STRUCTURE OF A TSH RECEPTOR MONOCLONAL ANTIBODY PROVIDES EVIDENCE THAT A TRIMER OF THE SHED RECEPTOR A-SUBUNIT IS THE CRITICAL IMMUNOGEN IN GRAVES' DISEASE; C.R. Chen, P. Hubbard, S.M. McLachlan, R. Murali, B. Rapoport
Chun-Rong Chen, MD
Cedars-Sinai Medical Center
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 9:00 AM-10:00 AM
Highlighted Oral Abstract Session
Highlighted Oral 3, Autoimmunity, Translational: DEVELOPMENT OF A UNIQUE MOUSE MODEL FOR GRAVES' DISEASE THAT SPONTANEOUSLY DEVELOPS PATHOGENIC TSH RECEPTOR ANTIBODIES; S.M. McLachlan, H. Aliesky, B. Banuelos, B. Rapoport
Sandra M. McLachlan, PhD
Cedars-Sinai Medical Center
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 9:00 AM-10:00 AM
Highlighted Oral Abstract Session
Highlighted Oral 4, Thyroid & Development, Basic: DIFFERENTIATION OF HUMAN EMBRYONIC STEM (HES) CELLS INTO THYROID CELLS; R. Ma, R. Latif, T.F. Davies
Risheng Ma, PhD
Mount Sinai
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 9:00 AM-10:00 AM
MTP: Management of Persistent/Recurrent Differentiated Thyroid Cancer: When to Treat, When to Watch?
MTP: Management of Persistent/Recurrent Differentiated Thyroid Cancer: When to Treat, When to Watch?
Mona M. Sabra, MD
Memorial Sloan-Kettering Cancer Center
Gary L. Clayman, MD, FACS
The University of Texas M. D. Anderson Cancer Center
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 11:00 AM-12:00 PM
MTP: Thyroid Disease and Pregnancy
MTP: Thyroid Disease and Pregnancy
Robin P. Peeters, MD
Erasmus MC, Rotterdam
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 11:00 AM-12:00 PM
Sidney H. Ingbar Award Lecture
Role of Thyroid Hormones in Skeletal Development and Bone Maintenance
Graham R. Williams, MB, PhD
Imperial College London
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 1:00 PM-1:45 PM
Basic Oral Abstract Session 1
Oral Abstract 5, Thyroid Cancer, Basic: KRASG12D MEDIATED ONCOGENIC TRANSFORMATION OF THYROID FOLLICULAR CELLS REQUIRES LONG-TERM TSH STIMULATION AND IS REGULATED BY SPRY1; Yufei Shi, M. Zou, E. Baitei, R. Al-Rijjal, R. Parhar, F. Al-Mohanna, S. Kimura, C. Pritchard, A. Alzahrani, A. Assiri, B. Meyer
Yufei Shi, MD
King Faisal Specialist Hospital
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 1:50 PM-3:20 PM
Basic Oral Abstract Session 1
Oral Abstract 6, Thyroid Cancer, Basic: SEX HORMONES REGULATE THYROID CANCER INITIATION AND PROGRESSION BY MODIFYING TUMOR SUPPRESSOR GENE EXPRESSION AND TUMOR IMMUNITY; Lisa J. Zhang, Y. Xiong, N. Nilubol, M. He, S. Bommareddi, X. Zhu, L. Jia, Z. Xiao, J. Park, X. Xu, D. Patel, M.C. Willingham, S. Cheng, E. Kebebew
Lisa J. Zhang, PhD
NCI/NIH
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 1:50 PM-3:20 PM
Basic Oral Abstract Session 1
Oral Abstract 7, Thyroid Cancer, Basic: COOPERATIVE ACTIVATION OF TERT BY BRAF V600E AND TERT PROMOTER MUTATIONS: A NOVEL MOLECULAR MECHANISM IN THYROID TUMORIGENESIS; Rengyun Liu, M. Xing
Rengyun Liu, PhD
Johns Hopkins University School of Medicine
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 1:50 PM-3:20 PM
Basic Oral Abstract Session 1
Oral Abstract 8, Iodine Uptake & Metabolism, Basic: EFFECTIVE 131I THERAPY OF METASTATIC COLON CANCER AFTER MESENCHYMAL STEM CELL-MEDIATED TUMOR STROMA TARGETING OF THE SODIUM IODIDE SYMPORTER; K. Knoop, N. Schwenk, K.A. Schmohl, A. Mueller, C. Zach, C. Cyran, J. Carlsen, G. Böning, P. Bartenstein, B. Göke, E. Wagner, P.J. Nelson, Christine Spitzweg
Christine Spitzweg, MD
University Hospital of Munich
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 1:50 PM-3:20 PM
Basic Oral Abstract Session 1
Oral Abstract 9, Thyroid Cancer, Basic: BRAF ACTIVATES AND PHYSICALLY INTERACTS WITH PAK TO REGULATE CELL MOTILITY; Samantha K. McCarty, M. Saji, X. Zhang, L.S. Kirschner, S. Fernandez, M.D. Ringel
Samantha K. McCarty, PhD
The Ohio State University
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 1:50 PM-3:20 PM
Basic Oral Abstract Session 1
Oral Abstract 10, Thyroid Cancer, Basic: BRAFV600E-DRIVEN MURINE ANAPLASTIC THYROID CANCERS RECUR AFTER WITHDRAWAL OF THE ONCOPROTEIN, AND REACTIVATE MAPK SIGNALING IN A BRAFV600E-INDEPENDENT MANNER; Jeffrey A. Knauf, K. Chen, R.A. Ghossein, J. Fagin
Jeffrey A. Knauf, MD
Memorial Sloan-Kettering Cancer Center
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 1:50 PM-3:20 PM
Clinical Oral Abstract Session 1
Oral Abstract 11, Thyroid Cancer, Clinical: LONG-TERM MODERATE THYROID HORMONE SUPPRESSION THERAPY IS ASSOCIATED WITH IMPROVED OUTCOMES IN DIFFERENTIATED THYROID CARCINOMA: NATIONAL THYROID CANCER TREATMENT COOPERATIVE STUDY GROUP REGISTRY ANALYSIS 1987-2012; Aubrey Carhill, D.R. Litofsky, K. Ain, J. Brierley, D.S. Cooper, H. Fein, B. Haugen, J. Jonklaas, P. Ladenson, J. Magner, D. Ross, M. Skarulis, D. Steward, M. Xing, H. Maxon, S.I. Sherman
Aubrey Carhill, MD
The University of Texas MD Anderson Cancer Center
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 1:50 PM-3:20 PM
Clinical Oral Abstract Session 1
Oral Abstract 12, Autoimmunity, Clinical: INDUCTION OF PAINLESS THYROIDITIS IN PATIENTS RECEIVING PROGRAMMED DEATH 1 RECEPTOR IMMUNOTHERAPY FOR METASTATIC MALIGNANCIES; S. Orlov, F. Salari, L. Kashat, J. Alfaifi, Paul G. Walfish
Paul G. Walfish, MD
Mount Sinai Hospital
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 1:50 PM-3:20 PM
Clinical Oral Abstract Session 1
Oral Abstract 13, Thyroid Cancer, Clinical: PROGNOSTIC AND PREDICTIVE FACTORS CORRELATED WITH TREATMENT OUTCOMES FOR RADIOACTIVE IODINE-REFRACTORY DIFFERENTIATED THYROID CANCER (RAI-RDTC) PATIENTS RECEIVING SORAFENIB OR PLACEBO ON THE PHASE III DECISION TRIAL; M. Schlumberger, R. Elisei, F. Pacini, B. Jarzab, L. Giannetta, L. Bastholt, C. De la Fouchardiere, R. Paschke, F. Worden, Y. Shong, J. Smit, C. Kappeler, I. Molnar, M.S. Brose
Martin Schlumberger, MD
Institute Gustave-Roussy
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 1:50 PM-3:20 PM
Clinical Oral Abstract Session 1
Oral Abstract 14, Thyroid Cancer, Clinical: IS PREOPERATIVE VITAMIN D DEFICIENCY A RISK FACTOR FOR POSTOPERATIVE SYMPTOMATIC HYPOCALCEMIA IN THYROID CANCER PATIENTS UNDERGOING TOTAL THYROIDECTOMY PLUS CENTRAL COMPARTMENT NECK DISSECTION?; W. Kim, J. Jeong, S. Jung, C. Lee, S. Kang, J. Lee, J.; Jung, Kee Hyun Nam, W. Chung, C. Park
Kee Hyun Nam
Yonsei University College of Medicine
from 84th Annual Meeting of the American Thyroid Association on October 30, 2014 1:50 PM-3:20 PM
<< first | < prev page: of 5 records per page: next > | last >>
pages: 1 2 3 4 5 presentations: 1 to 25 of 123 from 84th Annual Meeting of the American Thyroid Association